Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ancient herbal blend put to the test for chronic insomnia relief

NCT ID NCT06511011

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This phase 2 trial tests whether a traditional Chinese herbal formula, modified Suan ZaoRen Tang-TianWang BuXin Dan (mSZT-TBD), can improve sleep quality in adults with chronic insomnia. Participants will receive either the herbal granules or a placebo for six weeks. The study measures changes in sleep quality using a standard questionnaire.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a Chinese herbal formula called modified Suan ZaoRen Tang-TianWang BuXin Dan (mSZT-TBD)
What this could lead to
If effective, this herbal formula could offer a new treatment option for chronic insomnia with fewer side effects than standard medications.
What could go wrong
This is a small phase 2 trial, so results may not be conclusive. Herbal formulas can vary in quality and may interact with other medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 76 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age from 18 to 65 years; * Eligible for the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, criteria for insomnia disorder. The criteria include having difficulties in falling asleep, difficulties in staying asleep, or early morning awakening with clinically significant consequences for daily life for at least 3 nights per week for at least 6 months; * Insomnia Severity Index (ISI) total score of at least 8 indicating insomnia at the clinical level; * Diagnosed to be Yin deficiency-induced internal heat pattern according to traditional Chinese Medicine (TCM) theory; * Able to complete questionnaires and take medications as scheduled; and * Voluntary written consent. Exclusion Criteria: * Known nervous system disease (eg, stroke, Parkinson's Disease); * Known mental disorders (eg, depression or anxiety) or HADS score 11 or above in any either item; * Known sleeping related diseases (eg. sleep apnea, nocturnal myoclonus, restless legs, severe nocturnal enuresis or narcolepsy) that may affect the sleeping quality; * Known pharmacologically induced insomnia; * With symptoms that significantly disturb sleep such as pain, fever, diarrhea, frequent micturition, and cough; * Know treatment to comorbid sleep disorders, such as sleep apnea or narcolepsy; * Work on shift or on night shift; * Concomitant pharmacological treatment or herbal medicines for insomnia within the past month; * Known severe medical conditions, such as cardiovascular, liver, kidney or hematopoietic system disease, diabetes mellitus, cancers, cerebrovascular diseases; * Impaired hematological profile and liver / renal function exceeds the upper limit of the reference value by 2 times; * Known alcohol and / or drug abuse; * Known allergic history to any Chinese herbal medicines; * Diagnosed to be deficiency of spleen according to TCM theory; * Any contraindications for taking Chinese medicines in the opinion of the investigators; * Know pregnant or lactating; and * Involved in other interventional clinical studies at the same time.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insomnia chronic are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hong Kong Institute of Integrative Medicine

    RECRUITING

    Shatin, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.